Description
TAS::36 0160::TAS PHARM PRIME VENDR EXPRESS RPT
First action · last action
2010-05-01 · 2010-05-01
Transactions
1
First transaction's obligation
$364,302
Base + all options value (sum of deltas)
$364,302
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
8
SDVOSB flag on record
No
Parent IDV
V797P1020
NAICS
424210 · DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2010-05-01+$364,302= $364,302
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2010-05-01 | +$364,302 | $364,302 | TAS::36 0160::TAS PHARM PRIME VENDR EXPRESS RPT |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI S1RUKWWRYFL6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24126F0121 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $16,333 | FY2026 |
| 36C24226P0805 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $16,333 | FY2026 |
| 36C24026K1010 | VHA CHIEF LOGISTICS OFFICE (36C240) · 6505 · DRUGS AND BIOLOGICALS | $1,194,619,137 | FY2026 |
| 36C24026K1009 | VHA CHIEF LOGISTICS OFFICE (36C240) · 6505 · DRUGS AND BIOLOGICALS | $1,191,973,258 | FY2026 |
| 36C26226P1049 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $220,957 | FY2026 |
| 36C24026K1008 | VHA CHIEF LOGISTICS OFFICE (36C240) · 6505 · DRUGS AND BIOLOGICALS | $1,398,025,092 | FY2026 |
Other recipients under 6505 from 405-WHITE RIVER JUNCTION (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA405A10691 | SANOFI VACCINES US INC. | 405-WHITE RIVER JUNCTION | $80,189 | FY2011 |
| VA405P11932 | ASD SPECIALTY HEALTHCARE, LLC | 405-WHITE RIVER JUNCTION | $19,966 | FY2011 |
| V405P02035 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 405-WHITE RIVER JUNCTION | $4,852 | FY2010 |
| V405P01696 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 405-WHITE RIVER JUNCTION | $4,769 | FY2010 |
| V405A00552 | APHENA PHARMA SOLUTIONS-TENNESSEE, LLC | 405-WHITE RIVER JUNCTION | $7,538 | FY2010 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_V405PPVFY10MAY_3600_V797P1020_3600 · retrieved 2026-09-26.